Airway Vista

Today : Feb 11 2026

D -

0 4 5

Airway Vista 2024 :: Global Strategy and Multiomics Approach in Airway Diseases
Airway Vista 2023 :: Recent Novel Approaches for Better Understanding of Airway Diseases
Airway Vista 2022 :: COPD & Asthma : From Bench To Clinical Practice
Airway Vista 2021 :: Recent Advances in Precision Medicine of Airway Diseases
Airway Vista 2020 :: Recent Advances in Precision Medicine of Airway Diseases
Airway Vista 2019 :: Inspiration for the New Generation
Airway Vista 2018 :: Inspiration for the New Generation
Airway Vista 2017 :: Past 10-Year Progress and Future Perspective
Airway Vista 2016 :: Recent paradigm shifting in COPD & Asthma
Airway Vista 2015 :: From Phenotyping to Personalized Medicine
Airway Vista 2014 :: Comprehensive Approach leading to Personalized Medicine
Airway Vista 2013 :: THE ENVIRONMENT SERIOUSLY WITH THE HUMAN
Airway Vista 2012 :: GOLD Update & OLD Debate
Airway Vista 2011 :: COPD & Asthma: Basic to Comprehensive Understanding
Airway Vista 2010 :: Obtimal Understanding and Management of Obstructive Lung Disease
Airway Vista 2009 :: Overcome the Limitation of Airflow in Chronic Obstructive Lung Disease
Airway Vista 2008 :: Perspective toward Optimism in COPD & Severe Asthma

Conference Information
Scientific
- Scientific Program
- Invited Speakers
Registration
Gallery
General Information
- Korea & Seoul
- Useful Information

Conference Information

Invitation
Information
Organizing Committee
Scientific Committee
History
Contact Us

Scientific

Scientific Program
Invited Speakers

Registration

How to register
International Registration
Korean Registration
Confirmation

Gallery

General Information

Korea & Seoul
Useful Information

Gallery

Gallery
Gallery

Gallery
Gallery
- Gallery

Gallery

Gallery

Gallery

Obstructive Lung diseases Research Foundation, 88, Olympic-ro, 43-gil, Songpa-gu, Seoul, (Zip 05505) South Korea

Tel. +82-2-3010-4652 | Fax. +82-2-3010-4650 | Email. copdasthma@amc.seoul.kr

Name. Oh, Yeon-mok | No. 215-82-73173

© OLDRF ALL RIGHT RESERVED. IF YOU HAVE ANY QUESTIONS OR COMMENTS, PLEASE CONTACT US.